Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
YS-035 is a verapamil derivative that dose-dependently blocks calcium uptake via Na+/Ca2+ exchange in diverse types of cells (Ki = 28 µM).1 It inhibits calcium uptake by muscle cells, brain synaptosomes, and kidney fibroblasts.1 YS-035 also prevents calcium release from mitochondria induced by Ruthenium Red but not by uncouplers, respiratory inhibitors, or a chelating agent.1 YS-035 is used to characterize the role of calcium currents in smooth muscle and neuronal electrophysiology.2,3
WARNING This product is not for human or veterinary use.
1. Properties of a new calcium ion antagonist on cellular uptake and mitochondrial efflux of calcium ions. Biochem. J. 218, 899-905 (1984).
2. Electrophysiological characterization of class III activity of a verapamil derivative in guinea-
3. Hyperpolarization-